This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Therapeutic Drug Monitoring Markets

Table 2.3: Key Attributes of Therapeutic Drug Monitoring 17

Table 2.4: Process of Therapeutic Drug Monitoring 26

Table 2.5: Information required to correctly interpret TDM concentration 27

Table 3.1: Monitored Therapeutic Drugs by Category and Indications 29

Table 3.2: Commonly Monitored Drugs 30

Table 3.3: Common Antiepileptic Drugs that undergo Therapeutic Drug Monitoring

30

Table 3.4: Proposed Therapeutic Range for newer Antiepileptics 31

Table 3.5: Antiepileptic Drug Monitoring Indications 31

Table 3.6: Application of Therapeutic Ranges for Antiepileptic Therapies 31

Table 3.7: Classification and examples of Antiarrhythmic Agents 33

Table 3.8 Antiarrhythmic Drugs, Indication and Therapeutic Range 33

Table 3.9: Commonly Prescribed Antiarrhythmic Drugs 33

Table 3.10: Recommended Collection Logistics and Sampling times for

Antiarrhythmic Therapeutic

Monitoring 34

Table 3.11: Analytical Issues in Monitoring Cardiac Drugs 34

Table 3.12: Drug Interactions Observed for Cardiac Drugs 34

Table 3.13: Short Term Side Effects of Lithium 36

Table 3.14: Long Term Side Effects of Lithium 36

Table 3.15: Classification of Antineoplastic agents 37

Table 3.16: General Toxicities of Antineoplastic Drugs 38

Table 3.17: Toxic effects of Methotrexate 38

Table 3.18: Therapeutic Range of Common Bronchodilators 39

Table 3.19: Toxic effects of Theophylline 39

Table 3.20: Toxic effects of Caffeine 39

Table 3.21: Common Antibiotics and their Therapeutic Ranges used in Therapeutic

Drug Monitoring 40

Table 3.22: Types of Immunosuppressant Therapeutics 41

Table 3.23: Non-steady State Kinetics of Immunosuppressant's in Therapeutic Drug

Monitoring 42

Table 3.24: Common Immunosuppressant Agents in Therapeutic Drug Monitoring 42

Table 3.25: European and U.S. Guidelines for Therapeutic Drug Monitoring of

Antiretroviral Drugs 44

Table 3.26: Antiretroviral Therapy in Children in Low- and Middle-Income

Countries 45

Table 3.27: Antiretroviral Therapy Coverage in Low- and Middle-Income Countries

45

Table 3.28: Suggested Minimum Trough Plasma Concentrations for Individuals with

Wild-Type HIV 46

Table 3.29: Guidelines for Therapeutic Management of Antiretroviral Drugs 47

4 of 10

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs